title: Peril in perishing pericytes.
authors: MRC Centre for Regenerative Medicine, Edinburgh, UK Dept of Orthopaedic Surgery and Broad Stem Cell Center, University of California, Los Angeles, USA bpeault@mednet.ucla.edu.
authors: Bruno
authors: B
authors: Péault
mesh_terms: D020533:Angiogenesis Inhibitors / Q000008:administration & dosage / Q000009:adverse effects* / Q000494:pharmacology*; D000818:Animals; D001943:Breast Neoplasms / Q000098:blood supply / Q000188:drug therapy; D039481:CD11b Antigen / Q000378:metabolism; D018827:Carcinoma, Lewis Lung / Q000188:drug therapy / Q000473:pathology; D015687:Cell Hypoxia; D005260:Female; D020868:Gene Silencing; D006801:Humans; D015850:Interleukin-6 / Q000235:genetics; D008546:Melanoma, Experimental / Q000188:drug therapy / Q000473:pathology; D022423:Myeloid Cells; D009336:Necrosis; D009369:Neoplasms / Q000098:blood supply / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology*; D009389:Neovascularization, Pathologic / Q000188:drug therapy*; D020286:Pericytes / Q000187:drug effects* / Q000276:immunology* / Q000473:pathology; D020574:Proto-Oncogene Proteins c-sis / Q000378:metabolism*; D019707:Receptors, Chemokine / Q000378:metabolism
chemical_list: D020533:Angiogenesis Inhibitors; D039481:CD11b Antigen; C503133:Gr-1 protein, mouse; D015850:Interleukin-6; D020574:Proto-Oncogene Proteins c-sis; D019707:Receptors, Chemokine